DEBORAH GRAVIL: Open Payments
NPI 1225328040 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,118 in 90 payments from 30 companies in 2025. Trend: 2023 $783 · 2024 $1,189 · 2025 $2,118
Food & beverage: $2,118
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 6 | $239 |
| E.R. Squibb & Sons, L.L.C. | 9 | $212 |
| PFIZER INC. | 12 | $191 |
| Amgen Inc. | 10 | $171 |
| Verona Pharma, Inc. | 7 | $122 |
| Axsome Therapeutics, Inc. | 1 | $116 |
| Phathom Pharmaceuticals, Inc. | 1 | $115 |
| Vital Connect, Inc | 2 | $92 |
| Corcept Therapeutics | 1 | $75 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $65 |
Products named: CAMZYOS, ELIQUIS, Ohtuvayre, Auvelity, VOQUEZNA, VITALPATCH RTM, REPATHA, OTEZLA.
Industry payments across KY — which companies pay providers there.
